Literature DB >> 19408092

A case of an anaplastic ependymoma with gliosarcomatous components.

Tomoaki Kano1, Hayato Ikota, Hirochiyo Wada, Susumu Iwasa, Shuhei Kurosaki.   

Abstract

A 29-year-old woman presented with a severe headache. Computed tomography revealed a large cystic lesion with a mural nodule-like mass homogeneously enhanced with contrast medium in the right cerebellum. The tumor was removed, and pathological studies revealed a cerebellar astrocytoma corresponding to World Health Organization grade II. When she was 35 years old, or 6 years after the surgery, magnetic resonance imaging revealed a recurrence of the tumor in the right cerebellum, and subtotal removal of the recurrent tumor was performed. Pathological studies revealed a mixed glioblastoma multiforme and anaplastic ependymoma. Chemotherapy (Paraplatin and VePeside-S) and focal radiation therapy at 60 Gy were administered following surgery. Thereafter, at 39 years of age, or 4 years after radiation therapy, magnetic resonance imaging again revealed a recurrence of the tumor, which was heterogeneously enhanced with gadoliniumdiethylenetriamine pentaacetic acid in the right cerebellum. Subtotal removal of the tumor was performed; pathological studies revealed an anaplastic ependymoma with sarcomatous components. Immunohistochemical findings showed some parts of the sarcomatous components to stain positively for glial fibrillary acidic protein and, as a result, these sarcomatous components were diagnosed to be gliosarcoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408092     DOI: 10.1007/s10014-008-0240-x

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  1 in total

1.  Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation.

Authors:  Abeer Z Tabbarah; Austin W Carlson; Angelica Oviedo; Rhett P Ketterling; Fausto J Rodriguez
Journal:  Clin Neuropathol       Date:  2012 May-Jun       Impact factor: 1.368

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.